HCM priced their IPO on the US market (NASDAQ:HCM) at $13.50. The shares already trade in London (AIM:HCM).
Investors can find plenty of details in the HCM IPO roadshow slide deck but there are some major takeaways here:
- China will be a huge market for healthcare - per capita spending today is $322 versus over $8K in the US. End markets there are growing between 15% and 20% per year.
- HCM uses a hybrid strategy - they are a major drug seller and distributor and they use that growing profitable cash flow to . . .